The COVID-19 pandemic will have a negative impact on the European diagnostic imaging equipment servicing market in the short term. Once the market stabilizes, however, the European diagnostic imaging equipment servicing market will be driven largely by an aging installed base across modalities, which is supporting new system replacements, coupled with an expanding patient population in the region. However, hospital budget constraints across Europe will dampen growth, and the market will remain relatively stagnant throughout the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diagnostic imaging equipment servicing in Europe across a 10-year period.

The COVID-19 pandemic will affect the diagnostic imaging equipment servicing market.

To what extent will the COVID-19 pandemic impact the European diagnostic imaging equipment servicing system market?

How will the impact of the COVID-19 pandemic different between segments?

How quickly are markets expected to rebound?

Shift toward purchasing of high-end, premium equipment in recent years is slowly changing the composition of the installed base. 

How has increase financial concern affected the way in which facilities approach their equipment purchasing strategies and equipment servicing strategies?

How will the uptake of these premium systems affect the ASPs of service contracts?

The European diagnostic imaging equipment servicing market is dominated by large, multimodality OEMs.

What factors help the OEMs to maintain competitive edge in the servicing market?

What strategies are ISOs using to gain share in the market?

Table of contents

  • Diagnostic Imaging Equipment Servicing - Market Insights - Europe

Author(s): Nidhi Nagrath

Nidhi Nagrath is a research associate within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the gastrointestinal endoscopy device and diagnostic imaging system servicing markets. Nidhi holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.